UDPG/P2Y-STAT1轴介导LPS诱导的反应性星化
Meng-Yao Wang1, Yuan-Hong Deng1, Xiao-Feng Ran1
1International Joint Research Centre on Purinergic Signalling/School of Health and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
Neuropharmacology
|October 16, 2025
概括
星球细胞表达功能性P2Y14受体,调节神经炎症. 准这种受体通路为中枢神经系统炎症状况提供了一种新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 星球细胞在中枢神经系统 (CNS) 神经炎症中至关重要.
- 纯能G蛋白结合受体P2Y14与神经炎症有关,但其在星球细胞中的作用尚不清楚.
- 了解星体P2Y14的功能对于神经炎症研究至关重要.
研究的目的:
- 为了研究P2Y14受体表达和分布在星球细胞中.
- 阐明P2Y14在星细胞炎症反应中的调节作用.
- 探索涉及UDPG/P2Y14-STAT1信号轴的潜在分子机制.
主要方法:
- 使用初级小鼠星体细胞和C8-D1A细胞系.
- 免疫光,西部斑点和RT-qPCR证实了P2Y14的表达.
- 药理学剂 (PPTN,UDPG) 和lentiviral转导调节P2Y14的活性和表达.
主要成果:
- P2Y14受体在星球细胞中表达,它们的表达在LPS刺激时会增加.
- 通过UDPG激活P2Y14,促进星球细胞激活 (GFAP表达) 和炎症媒介释放 (IL-6,IL-18,TNF-α).
- 抗 P2Y14 抗体 PPTN 抑制 GFAP 表达和炎性细胞因子释放,部分通过 STAT1/p-STAT1 途径.
结论:
- 星球细胞表达功能性P2Y14受体,在神经炎症中发挥关键作用.
- UDPG/P2Y14-STAT1信号通路是天体细胞炎症反应的关键调节者.
- P2Y14代表了中枢神经系统炎症性疾病的潜在治疗标.
相关概念视频
IP3/DAG Signaling Pathway
14.2K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
14.2K
GPCRs Regulate Adenylyl Cylase Activity
7.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.3K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
GPCR Desensitization
7.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.9K


